Stock Track | Orthofix Medical Soars 5.67% on Strong Q3 Results, Beating Analyst Estimates

Stock Track

Nov 04

Orthofix Medical Inc. (NASDAQ: OFIX) saw its stock price surge 5.67% in pre-market trading on Tuesday, following the release of its impressive third-quarter financial results. The medical device company specializing in spine and orthopedic solutions outperformed analyst expectations, demonstrating robust growth across key metrics.

The company reported Q3 net sales of $205.6 million, a 5% year-over-year increase, surpassing the consensus estimate of $200 million. Adjusted EBITDA for the quarter reached $24.6 million, marking a significant 28.2% year-over-year growth and exceeding analyst projections of $20.1 million. Orthofix also posted a strong gross margin of 72.2% for the quarter.

Driving this performance were several factors, including an 8% growth in U.S. Spine Fixation net sales, bolstered by the 7D FLASH™ navigation technology. The Bone Growth Therapies segment saw a 6% increase in net sales, while U.S. Orthopedics net sales jumped by an impressive 19%, aided by the launch of TrueLok™ Elevate. In light of these results, Orthofix has narrowed its full-year 2025 net sales guidance to $810-$814 million and raised the low end of its adjusted EBITDA guidance to $84-$86 million, signaling continued confidence in its growth trajectory.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1137635617"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137635617\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137635617?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-04 22:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137635617","market":"hk","top_or_hot":-1,"title":"Stock Track | Orthofix Medical Soars 5.67% on Strong Q3 Results, Beating Analyst Estimates","media":"Stock Track","content":"<p>Orthofix Medical Inc. (NASDAQ: OFIX) saw its stock price surge 5.67% in pre-market trading on Tuesday, following the release of its impressive third-quarter financial results. The medical device company specializing in spine and orthopedic solutions outperformed analyst expectations, demonstrating robust growth across key metrics.</p>\n\n<p>The company reported Q3 net sales of $205.6 million, a 5% year-over-year increase, surpassing the consensus estimate of $200 million. Adjusted EBITDA for the quarter reached $24.6 million, marking a significant 28.2% year-over-year growth and exceeding analyst projections of $20.1 million. Orthofix also posted a strong gross margin of 72.2% for the quarter.</p>\n\n<p>Driving this performance were several factors, including an 8% growth in U.S. Spine Fixation net sales, bolstered by the 7D FLASH™ navigation technology. The Bone Growth Therapies segment saw a 6% increase in net sales, while U.S. Orthopedics net sales jumped by an impressive 19%, aided by the launch of TrueLok™ Elevate. In light of these results, Orthofix has narrowed its full-year 2025 net sales guidance to $810-$814 million and raised the low end of its adjusted EBITDA guidance to $84-$86 million, signaling continued confidence in its growth trajectory.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Orthofix Medical Soars 5.67% on Strong Q3 Results, Beating Analyst Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Orthofix Medical Soars 5.67% on Strong Q3 Results, Beating Analyst Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-04 22:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orthofix Medical Inc. (NASDAQ: OFIX) saw its stock price surge 5.67% in pre-market trading on Tuesday, following the release of its impressive third-quarter financial results. The medical device company specializing in spine and orthopedic solutions outperformed analyst expectations, demonstrating robust growth across key metrics.</p>\n\n<p>The company reported Q3 net sales of $205.6 million, a 5% year-over-year increase, surpassing the consensus estimate of $200 million. Adjusted EBITDA for the quarter reached $24.6 million, marking a significant 28.2% year-over-year growth and exceeding analyst projections of $20.1 million. Orthofix also posted a strong gross margin of 72.2% for the quarter.</p>\n\n<p>Driving this performance were several factors, including an 8% growth in U.S. Spine Fixation net sales, bolstered by the 7D FLASH™ navigation technology. The Bone Growth Therapies segment saw a 6% increase in net sales, while U.S. Orthopedics net sales jumped by an impressive 19%, aided by the launch of TrueLok™ Elevate. In light of these results, Orthofix has narrowed its full-year 2025 net sales guidance to $810-$814 million and raised the low end of its adjusted EBITDA guidance to $84-$86 million, signaling continued confidence in its growth trajectory.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OFIX","symbol_name":"Orthofix International N.V.","start_time":0,"source_url":"","article_id":"1137635617","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137635617","pubTimestamp":1762266970,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Orthofix Medical Inc. (NASDAQ: OFIX) saw its stock price surge 5.67% in pre-market trading on Tuesday, following the release of its impressive third-quarter financial results. The medical device...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OFIX":"Orthofix International N.V."},"translate_title":"个股追踪|Orthofix Medical第三季度业绩强劲飙升5.67%，超出分析师预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OFIX":1},"content_text":"Orthofix Medical Inc. (NASDAQ: OFIX) saw its stock price surge 5.67% in pre-market trading on Tuesday, following the release of its impressive third-quarter financial results. The medical device company specializing in spine and orthopedic solutions outperformed analyst expectations, demonstrating robust growth across key metrics.\nThe company reported Q3 net sales of $205.6 million, a 5% year-over-year increase, surpassing the consensus estimate of $200 million. Adjusted EBITDA for the quarter reached $24.6 million, marking a significant 28.2% year-over-year growth and exceeding analyst projections of $20.1 million. Orthofix also posted a strong gross margin of 72.2% for the quarter.\nDriving this performance were several factors, including an 8% growth in U.S. Spine Fixation net sales, bolstered by the 7D FLASH™ navigation technology. The Bone Growth Therapies segment saw a 6% increase in net sales, while U.S. Orthopedics net sales jumped by an impressive 19%, aided by the launch of TrueLok™ Elevate. In light of these results, Orthofix has narrowed its full-year 2025 net sales guidance to $810-$814 million and raised the low end of its adjusted EBITDA guidance to $84-$86 million, signaling continued confidence in its growth trajectory.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}